| Q36414219 | An approach to the patient with fibromyalgia |
| Q48375432 | Chronic fatigue syndrome and fibromyalgia. Dilemmas in diagnosis and clinical management |
| Q40735882 | Does stress or trauma cause or aggravate rheumatic disease? |
| Q40589785 | Education programmes for fibromyalgia patients: description and evaluation |
| Q33892112 | Elevated plasma levels of neuropeptide Y in female fibromyalgia patients |
| Q74560207 | Evaluation of multimodal treatment program for fibromyalgia |
| Q24792992 | Factors explaining variance in perceived pain in women with fibromyalgia |
| Q37717335 | Fibromyalgia--which is the best treatment? A personalized, comprehensive, ambulatory, patient-involved management programme |
| Q38601633 | Fibromyalgia: A Critical and Comprehensive Review |
| Q40880093 | Fibromyalgia: an age-old malady begging for respect |
| Q60680874 | Fibrositis |
| Q48913186 | Fibrositis (Fibromyalgia Syndrome) and the Dental Clinician |
| Q39642170 | Fibrositis (fibromyalgia). A common non-entity? |
| Q68053051 | In vivo 31P magnetic resonance spectroscopy (MRS) of tender points in patients with primary fibromyalgia syndrome |
| Q33583676 | Individual and work related factors associated with symptoms of musculoskeletal complaints. II. Different risk factors among sewing machine operators |
| Q70624480 | Individual and work-related risk factors associated with symptoms of musculoskeletal complaints |
| Q41190645 | Losing face: sources of stigma as perceived by chronic facial pain patients |
| Q40589732 | Muscle function and origin of pain in fibromyalgia |
| Q34300675 | Musculoskeletal chest wall pain |
| Q33925727 | Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome |
| Q40589744 | Neuromediator and hormonal perturbations in fibromyalgia syndrome: results of chronic stress? |
| Q33542912 | Pain in fibromyalgia |
| Q36247921 | Personality and fibromyalgia syndrome |
| Q35696878 | Personality styles in patients with fibromyalgia, major depression and healthy controls |
| Q34280026 | Pharmacologic treatment of fibromyalgia |
| Q48894537 | Polysomnography in idiopathic muscle pain syndrome (fibrositis) |
| Q36060887 | Psychiatric comorbidity in fibromyalgia |
| Q40589760 | Psychological aspects of fibromyalgia syndrome: a component of the dysfunctional spectrum syndrome |
| Q47350299 | Psychological disturbance in fibromyalgia: relation to pain severity |
| Q68364360 | Psychological factors and self-reports of muscle pain |
| Q34746409 | Rational and targeted pharmacologic treatment of fibromyalgia |
| Q34085879 | Stress and rheumatic diseases. |
| Q37953249 | Tension myalgia as a diagnosis at the Mayo Clinic and its relationship to fibrositis, fibromyalgia, and myofascial pain syndrome |
| Q48361912 | The relationship between temporomandibular disorders and stress-associated syndromes |
| Q34207499 | The role of psychiatric disorders in fibromyalgia |
| Q43244209 | Visceral and somatic disorders: tissue softening with frequency-specific microcurrent |
| Q79334530 | [Psychosomatic aspects in the diagnosis and treatment of fibromyalgia] |